Liao 2000.
Methods |
Study design: randomized controlled trial, parallel group Unit of analysis: eyes Number randomized: 88 eyes in total, 44 per group Number of arms: 2 Enrollment start year: 1995 Length of follow‐up: 10 months or more Sample size calculations: not reported Losses to follow‐up: not reported |
|
Participants |
Country: Taiwan Age (mean (SD)): 57.9 (7.4) in the MMC group, 57.4 (10.2) in the EX‐DCR alone group Females (n (%)): not reported Inclusion criteria: patients with nasolacrimal duct obstruction Exclusion criteria: not reported Study group differences: no significant differences with regard to age |
|
Interventions |
Intervention: EX‐DCR with 0.2 mg/mL MMC application Comparison intervention: EX‐DCR alone |
|
Outcomes |
Measured outcomes:
Adverse events: wound disruption |
|
Identification |
Author name: Shu Lang Liao Institution: Department of Ophthalmology National Taiwan University Hospital Email: lang89@ha.mc.ntu.edu.tw |
|
Notes |
Funding source: not reported Declarations of interest: none Trial registration number: not reported |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Method of random sequence generation was not reported: "88 patients with a diagnosis of primary acquired nasolacrimal duct obstruction were randomly assigned into mitomycin C and conventional DCR groups". |
Allocation concealment (selection bias) | Unclear risk | Method of treatment allocation concealment was not reported. |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Authors state that "all the examinations were done by the same physician with double blind control"; however, details regarding masking and who was masked and how it was performed were not reported. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Authors state that "all the examinations were done by the same physician with double blind control", but unclear whether this means outcome assessors were masked. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | There were no missing data. |
Selective reporting (reporting bias) | Unclear risk | No trial or protocol registration available for comparison to ascertain selective outcome reporting. |
Other bias | Unclear risk | There was insufficient information to permit a judgement of 'low risk' or 'high risk'. |